Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Results
Phase 2
This trial looked at the drugs erlotinib and bevacizumab for non small cell lung cancer (NSCLC).
It was for people with NSCLC that had spread and had changes to genes affecting a protein called .
Recruitment start: 22 March 2012
Recruitment end: 9 October 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sanjay Popat
European Thoracic Oncology Platform (ETOP)
Roche
Last reviewed: 05 Aug 2018
CRUK internal database number: 10664
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
